Sherwin-Williams Company (The) Common Stock vs Health Care Select Sector SPDR Fund — how do they compare? Sherwin-Williams Company (The) Common Stock trades at $326.97 (market cap $78.78B), while Health Care Select Sector SPDR Fund trades at $176.43 (market cap $43.92B). The key difference: Sherwin-Williams Company (The) Common Stock is the larger of the two by market cap, and Sherwin-Williams Company (The) Common Stock pays a 0.99% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| SHW | XLV | |
|---|---|---|
Market Cap | $78.78B | $43.92B |
Volume | 1,403,311 | 11,816,834 |
Sector | Basic Materials | — |
52-Week High | $372.60 | $175.68 |
52-Week Low | $293.00 | $142.33 |
Enterprise Value | $92.71B | — |
Dividend Yield | 0.99% | — |
Typical Hold Time | — | 100 Days |
Signals from Pluang's Aura AI — not financial advice
Sherwin-Williams (SHW) trades at $324.10, up 1.21% with strong earnings momentum after beating estimates for three consecutive quarters. The stock shows neutral technical signals but maintains robust fundamentals with 65.12% ROE and expanding manufacturing capacity. Recent facility expansions in Statesville enhance production capabilities, positioning the company for continued market share gains.
Outlook remains positive with analyst consensus at Buy (57.9%) and $383.64 price target, though high valuation multiples (P/E 29.9) and competitive pressures present risks. Earnings growth and strategic investments support upside potential, while margin compression and economic sensitivity warrant monitoring.
XLV trades at $169.66, down 1.35% today, while maintaining a bullish technical outlook with strong moving average signals. The healthcare ETF's low 0.08% expense ratio and diversified exposure to 61 S&P 500 healthcare stocks provide cost-effective sector access. Recent news highlights XLV's defensive characteristics during potential Fed rate hikes and political volatility.
Outlook remains positive given healthcare's defensive positioning amid economic uncertainty, though overbought RSI levels suggest near-term consolidation. Key risks include sector-specific regulatory pressures and election-related policy uncertainty that could impact healthcare stocks through 2026.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
The Sherwin-Williams Company manufactures, develops, and distributes paints, coatings, and related products through three segments: Paint Stores Group, operating more than 4,900 company-owned stores selling Sherwin-Williams-branded products; Consumer Brands Group, selling brands such as Valspar, Dutch Boy, Krylon, and Minwax through mass merchandisers and home centers; and Performance Coatings Group, supplying industrial, construction, and transportation coatings in more than 120 countries.
Read more on SHW →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →